Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma (Q33482629)
scientific article
Language:
Current Data About Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma
(P31) (Q13442814)
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P304) 183-185
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P433) 1
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P478) 64
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P577) Tuesday, January 1, 1980
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P921) (Q42824440)

(P1433) (Q27710285)
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P1476) "Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma" (language: en)
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

(P2093) Schneider RJ
(P1545) 1
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

Woodcock TM
(P1545) 2
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

Yagoda A
(P1545) 3
(P248)
(P698) 6892892
(P813) Thursday, July 27, 2017

other details
description scientific article

External Links
(P698) 6892892